2.72
price down icon5.23%   -0.15
after-market After Hours: 2.72
loading
Alto Neuroscience Inc stock is traded at $2.72, with a volume of 117.40K. It is down -5.23% in the last 24 hours and up +12.86% over the past month. Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.
See More
Previous Close:
$2.87
Open:
$2.9
24h Volume:
117.40K
Relative Volume:
0.40
Market Cap:
$73.63M
Revenue:
-
Net Income/Loss:
$-49.81M
P/E Ratio:
-1.2616
EPS:
-2.156
Net Cash Flow:
$-42.93M
1W Performance:
-4.56%
1M Performance:
+12.86%
6M Performance:
-36.45%
1Y Performance:
-77.85%
1-Day Range:
Value
$2.71
$2.90
1-Week Range:
Value
$2.71
$3.08
52-Week Range:
Value
$1.60
$17.55

Alto Neuroscience Inc Stock (ANRO) Company Profile

Name
Name
Alto Neuroscience Inc
Name
Phone
773-255-5012
Name
Address
650 CASTRO STREET, SUITE 450, MOUNTAIN VIEW
Name
Employee
76
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ANRO's Discussions on Twitter

Compare ANRO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ANRO
Alto Neuroscience Inc
2.72 77.16M 0 -49.81M -42.93M -2.156
Biotechnology icon
ONC
Beigene Ltd Adr
240.41 25.57B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.10 111.79B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.30 39.90M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
591.85 65.28B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
73.93 6.31B 0 -153.72M -103.81M -2.00

Alto Neuroscience Inc Stock (ANRO) Upgrades & Downgrades

Date Action Analyst Rating Change
Oct-23-24 Downgrade Rodman & Renshaw Buy → Neutral
Oct-23-24 Downgrade Wedbush Outperform → Neutral
Sep-03-24 Initiated Wedbush Outperform
Feb-27-24 Initiated Jefferies Buy
Feb-27-24 Initiated Robert W. Baird Outperform
Feb-27-24 Initiated Stifel Buy
Feb-27-24 Initiated TD Cowen Outperform
Feb-27-24 Initiated William Blair Outperform
View All

Alto Neuroscience Inc Stock (ANRO) Latest News

pulisher
08:03 AM

Alto Neuroscience to Participate in Upcoming Investor Conferences - Business Wire

08:03 AM
pulisher
May 25, 2025

Northern Trust Corp Acquires 390,190 Shares of Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World

May 25, 2025
pulisher
May 23, 2025

HC Wainwright Issues Pessimistic Outlook for ANRO Earnings - Defense World

May 23, 2025
pulisher
May 19, 2025

Q2 Earnings Forecast for Alto Neuroscience Issued By Wedbush - Defense World

May 19, 2025
pulisher
May 18, 2025

Alto Neuroscience, Inc.: Promising Clinical Trials and Strong Financial Position Justify Buy Rating - TipRanks

May 18, 2025
pulisher
May 18, 2025

Equities Analysts Set Expectations for ANRO Q1 Earnings - Defense World

May 18, 2025
pulisher
May 17, 2025

Wedbush Reiterates Neutral Rating for Alto Neuroscience (NYSE:ANRO) - Defense World

May 17, 2025
pulisher
May 15, 2025

Alto Neuroscience Advances Precision Psychiatry Pipeline - TipRanks

May 15, 2025
pulisher
May 14, 2025

Alto Neuroscience Reports First Quarter 2025 Financial Results And Recent Business Highlights - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Alto Neuroscience Reports First Quarter 2025 Financial Results and Recent Business Highlights - Business Wire

May 14, 2025
pulisher
May 14, 2025

Alto Neuroscience, Inc. (NYSE:ANRO) Shares Acquired by Barclays PLC - Defense World

May 14, 2025
pulisher
May 13, 2025

Alto Neuroscience, Inc. (NYSE:ANRO) Receives $15.40 Average Target Price from Brokerages - Defense World

May 13, 2025
pulisher
May 12, 2025

Stifel Financial Corp Takes $544,000 Position in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World

May 12, 2025
pulisher
May 11, 2025

Alto Neuroscience (ANRO) Expected to Announce Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

Trading Day Triumph: Alto Neuroscience Inc (ANRO) Ends at 2.17, a -0.91 Surge/Plunge - DWinneX

May 08, 2025
pulisher
May 08, 2025

JPMorgan Chase & Co. Trims Stock Holdings in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World

May 08, 2025
pulisher
Apr 28, 2025

Alto Neuroscience presents new data at Society of Biological Psychiatry meeting - TipRanks

Apr 28, 2025
pulisher
Apr 28, 2025

Alto Neuroscience Presents New Data at the Society of Biological Psychiatry Annual Meeting Underscoring Precision Psychiatry Approach - Business Wire

Apr 28, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 22, 2025

Alto Neuroscience to Participate in the JonesResearch Virtual CNS Day - Business Wire

Apr 22, 2025
pulisher
Apr 18, 2025

Analysts Set Alto Neuroscience, Inc. (NYSE:ANRO) PT at $15.40 - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Alto Neuroscience, Inc. (NYSE:ANRO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat

Apr 17, 2025
pulisher
Apr 15, 2025

Wellington Management Group LLP Has $326,000 Stake in Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World

Apr 15, 2025
pulisher
Apr 11, 2025

Analysts Set Expectations for ANRO Q1 Earnings - Defense World

Apr 11, 2025
pulisher
Apr 08, 2025

Alto Neuroscience initiated with a Buy at H.C. Wainwright - Yahoo Finance

Apr 08, 2025
pulisher
Apr 08, 2025

Alto Neuroscience (NYSE:ANRO) Now Covered by Analysts at HC Wainwright - Defense World

Apr 08, 2025
pulisher
Apr 07, 2025

HC Wainwright & Co. Initiates Coverage of Alto Neuroscience (ANRO) with Buy Recommendation - Nasdaq

Apr 07, 2025
pulisher
Apr 01, 2025

Charles Schwab Investment Management Inc. Sells 32,137 Shares of Alto Neuroscience, Inc. (NYSE:ANRO) - Defense World

Apr 01, 2025
pulisher
Mar 30, 2025

Alto Neuroscience, Inc. (NYSE:ANRO) Shares Acquired by Bank of New York Mellon Corp - Defense World

Mar 30, 2025
pulisher
Mar 28, 2025

ANRO stock touches 52-week low at $2.33 amid market challenges - Investing.com Australia

Mar 28, 2025
pulisher
Mar 24, 2025

What is William Blair’s Forecast for ANRO Q1 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

What is Wedbush’s Estimate for ANRO FY2029 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

Brokerages Set Alto Neuroscience, Inc. (NYSE:ANRO) PT at $16.75 - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

William Blair Reiterates “Outperform” Rating for Alto Neuroscience (NYSE:ANRO) - Defense World

Mar 23, 2025
pulisher
Mar 21, 2025

Alto Neuroscience says its funded through 2028 - Green Market Report

Mar 21, 2025
pulisher
Mar 20, 2025

ALTO NEUROSCIENCE Earnings Results: $ANRO Reports Quarterly Earnings - Nasdaq

Mar 20, 2025
pulisher
Mar 20, 2025

Alto Neuroscience Inc. (ANRO) reports earnings - Quartz

Mar 20, 2025
pulisher
Mar 20, 2025

Alto Neuroscience Reports Full-Year 2024 Financial Results And Recent Business Highlights - Marketscreener.com

Mar 20, 2025
pulisher
Mar 20, 2025

Alto Neuroscience, Inc. SEC 10-K Report - TradingView

Mar 20, 2025
pulisher
Mar 20, 2025

Alto Neuroscience Reports Full-Year 2024 Financial Results and Recent Business Highlights - Business Wire

Mar 20, 2025
pulisher
Mar 13, 2025

Alto Neuroscience (ANRO) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 11, 2025

ANRO stock touches 52-week low at $3.23 amid market challenges - MSN

Mar 11, 2025
pulisher
Mar 11, 2025

Alto Neuroscience, Inc. (NYSE:ANRO) Shares Bought by Rhumbline Advisers - Defense World

Mar 11, 2025
pulisher
Mar 07, 2025

Schizophrenia Drugs Market: Top Competitors, Market Share, - openPR

Mar 07, 2025
pulisher
Mar 06, 2025

Alto Neuroscience (NYSE:ANRO) Trading Up 8.8% – Should You Buy? - Defense World

Mar 06, 2025
pulisher
Mar 04, 2025

Alto Neuroscience Is Down Nearly 35% This Year, But Retail Traders Keep Flocking To Micro-Cap Stock - Asianet Newsable

Mar 04, 2025
pulisher
Mar 04, 2025

1 ‘Strong Buy’ Penny Stock With 270% Upside to Load Up On in March - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

1 ‘Strong Buy’ Penny Stock With 270% Upside To Load Up On In March - Barchart

Mar 04, 2025

Alto Neuroscience Inc Stock (ANRO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$1.05
price down icon 8.70%
$30.28
price down icon 2.39%
$576.24
price down icon 0.61%
$285.56
price down icon 1.56%
$4.35
price up icon 1.64%
$73.93
price down icon 2.22%
Cap:     |  Volume (24h):